These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 4062970

  • 1. Role of adenosine uptake and metabolism by blood cells in the antiplatelet actions of dipyridamole, dilazep and nitrobenzylthioinosine.
    Dawicki DD, Agarwal KC, Parks RE.
    Biochem Pharmacol; 1985 Nov 15; 34(22):3965-72. PubMed ID: 4062970
    [Abstract] [Full Text] [Related]

  • 2. Potentiation of the antiplatelet action of adenosine in whole blood by dipyridamole or dilazep and the cAMP phosphodiesterase inhibitor, RA 233.
    Dawicki DD, Agarwal KC, Parks RE.
    Thromb Res; 1986 Jul 15; 43(2):161-75. PubMed ID: 3016942
    [Abstract] [Full Text] [Related]

  • 3. Adenosine metabolism in human whole blood. Effects of nucleoside transport inhibitors and phosphate concentration.
    Dawicki DD, Agarwal KC, Parks RE.
    Biochem Pharmacol; 1988 Feb 15; 37(4):621-6. PubMed ID: 3342099
    [Abstract] [Full Text] [Related]

  • 4. Significance of plasma adenosine in the antiplatelet activity of forskolin: potentiation by dipyridamole and dilazep.
    Agarwal KC, Zielinski BA, Maitra RS.
    Thromb Haemost; 1989 Feb 28; 61(1):106-10. PubMed ID: 2749584
    [Abstract] [Full Text] [Related]

  • 5. Role of plasma adenosine in the antiplatelet action of HL 725, a potent inhibitor of cAMP phosphodiesterase: species differences.
    Agarwal KC, Buckley RS, Parks RE.
    Thromb Res; 1987 Jul 15; 47(2):191-200. PubMed ID: 2821650
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of nucleoside and nucleobase transport and nitrobenzylthioinosine binding by dilazep and hexobendine.
    Plagemann PG, Kraupp M.
    Biochem Pharmacol; 1986 Aug 01; 35(15):2559-67. PubMed ID: 3741459
    [Abstract] [Full Text] [Related]

  • 7. Species differences in sensitivity of nucleoside transport in erythrocytes and cultured cells to inhibition by nitrobenzylthioinosine, dipyridamole, dilazep and lidoflazine.
    Plagemann PG, Woffendin C.
    Biochim Biophys Acta; 1988 Apr 02; 969(1):1-8. PubMed ID: 3349106
    [Abstract] [Full Text] [Related]

  • 8. A comparison of the abilities of nitrobenzylthioinosine, dilazep, and dipyridamole to protect human hematopoietic cells from 7-deazaadenosine (tubercidin).
    Cass CE, King KM, Montaño JT, Janowska-Wieczorek A.
    Cancer Res; 1992 Nov 01; 52(21):5879-86. PubMed ID: 1394215
    [Abstract] [Full Text] [Related]

  • 9. Transport and metabolism of 9-beta-D-arabinofuranosylguanine in a human T-lymphoblastoid cell line: nitrobenzylthioinosine-sensitive and -insensitive influx.
    Prus KL, Averett DR, Zimmerman TP.
    Cancer Res; 1990 Mar 15; 50(6):1817-21. PubMed ID: 2306735
    [Abstract] [Full Text] [Related]

  • 10. Role of nucleoside transport in drug action. The adenosine deaminase inhibitor, deoxycoformycin, and the antiplatelet drugs, dipyridamole and dilazep.
    Parks RE, Dawicki DD, Agarwal KC, Chen SF, Stoeckler JD.
    Ann N Y Acad Sci; 1985 Mar 15; 451():188-203. PubMed ID: 3878117
    [No Abstract] [Full Text] [Related]

  • 11. Transport and metabolism of adenosine in human erythrocytes: effect of transport inhibitors and regulation by phosphate.
    Plagemann PG.
    J Cell Physiol; 1986 Sep 15; 128(3):491-500. PubMed ID: 3488996
    [Abstract] [Full Text] [Related]

  • 12. Nitrobenzylthioinosine-sensitive nucleoside transport system: mechanism of inhibition by dipyridamole.
    Jarvis SM.
    Mol Pharmacol; 1986 Dec 15; 30(6):659-65. PubMed ID: 3785142
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of glucose uptake in murine cardiomyocyte cell line HL-1 by cardioprotective drugs dilazep and dipyridamole.
    Shuralyova I, Tajmir P, Bilan PJ, Sweeney G, Coe IR.
    Am J Physiol Heart Circ Physiol; 2004 Feb 15; 286(2):H627-32. PubMed ID: 14551048
    [Abstract] [Full Text] [Related]

  • 14. Mutation of leucine-92 selectively reduces the apparent affinity of inosine, guanosine, NBMPR [S6-(4-nitrobenzyl)-mercaptopurine riboside] and dilazep for the human equilibrative nucleoside transporter, hENT1.
    Endres CJ, Sengupta DJ, Unadkat JD.
    Biochem J; 2004 May 15; 380(Pt 1):131-7. PubMed ID: 14759222
    [Abstract] [Full Text] [Related]

  • 15. Characterization of inhibitor-sensitive and -resistant adenosine transporters in cultured human fetal astrocytes.
    Gu JG, Nath A, Geiger JD.
    J Neurochem; 1996 Sep 15; 67(3):972-7. PubMed ID: 8752102
    [Abstract] [Full Text] [Related]

  • 16. Nucleoside transport in rat erythrocytes: two components with differences in sensitivity to inhibition by nitrobenzylthioinosine and p-chloromercuriphenyl sulfonate.
    Jarvis SM, Young JD.
    J Membr Biol; 1986 Sep 15; 93(1):1-10. PubMed ID: 3025447
    [Abstract] [Full Text] [Related]

  • 17. Antimalarial action of nitrobenzylthioinosine in combination with purine nucleoside antimetabolites.
    Gero AM, Scott HV, O'Sullivan WJ, Christopherson RI.
    Mol Biochem Parasitol; 1989 Apr 15; 34(1):87-97. PubMed ID: 2651920
    [Abstract] [Full Text] [Related]

  • 18. Nucleoside transport inhibition and fMLP-stimulated whole blood luminescence.
    Ver Donck KL, Verheyen WJ, Van Belle H.
    J Mol Cell Cardiol; 1991 Jul 15; 23(7):783-5. PubMed ID: 1791629
    [Abstract] [Full Text] [Related]

  • 19. Saturable, high affinity binding of the nucleoside transport inhibitor, nitrobenzylthioinosine, to guinea pig cardiac membranes.
    Williams EF, Clanachan AS.
    Eur J Pharmacol; 1983 Jan 28; 87(1):133-6. PubMed ID: 6132821
    [Abstract] [Full Text] [Related]

  • 20. Adenosine transport and nitrobenzylthioinosine binding in human placental membrane vesicles from brush-border and basal sides of the trophoblast.
    Barros LF, Bustamante JC, Yudilevich DL, Jarvis SM.
    J Membr Biol; 1991 Jan 28; 119(2):151-61. PubMed ID: 1904498
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.